Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06927856 · ClinicalTrials.gov registry record · NA

The Test-to-PrEP Study

A NA study of HIV Infections, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
320
Enrollment target
1
Study location

NCT06927856 is a NA study of HIV Infections that is actively recruiting participants, run by University of Miami. The registered enrollment target is 320 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06927856, a NA study of HIV Infections, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
320 participants
Enrollment target
1
Study location

Study Summary

To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.

Conditions Studied

HIV Infections

Interventions

  • BEHAVIORAL Test-to-PrEP
  • BEHAVIORAL Access by Referral

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2025-04-10
Est. Completion 2028-07-01
Phase NA

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06927856

The ClinicalTrials.gov registry entry for NCT06927856 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (28% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Test-to-PrEP is the first listed.

NCT06927856 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06927856 about?

NCT06927856 is a clinical study titled "The Test-to-PrEP Study". To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.

What is the current status of trial NCT06927856?

This trial is currently recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2025-04-10. Estimated completion is 2028-07-01.

What conditions does trial NCT06927856 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT06927856?

The interventions under investigation include: Test-to-PrEP (BEHAVIORAL), Access by Referral (BEHAVIORAL).

Who is sponsoring clinical trial NCT06927856?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06927856 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.